Published in Int Immunopharmacol on May 30, 2006
Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol (2011) 1.02
HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis. Biochim Biophys Acta (2009) 1.00
Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS. J Biomed Nanotechnol (2015) 0.95
Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol (2007) 0.94
Endogenous opiates and behavior: 2006. Peptides (2007) 0.92
A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. J Neuroimmune Pharmacol (2011) 0.91
Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. J Neurovirol (2012) 0.90
Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS (2014) 0.87
Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder. AIDS Res Treat (2012) 0.86
Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system. J Cell Physiol (2012) 0.82
Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis. J Cell Physiol (2015) 0.78
Opioids Resistance in Chronic Pain Management. Curr Neuropharmacol (2017) 0.75
Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J Neuroimmunol (2004) 1.29
The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol (2009) 1.21
Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol (2007) 1.18
Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol (2008) 1.09
Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol (2005) 1.01
Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend (2012) 0.95
Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol (2009) 0.93
Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells. Amino Acids (2011) 0.92
Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells. J Pharmacol Exp Ther (2003) 0.92
Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One (2013) 0.91
Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats. J Neuroimmune Pharmacol (2010) 0.87
Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res (2013) 0.86
Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells. J Neuroimmunol (2004) 0.86
Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages. Mol Pharmacol (2012) 0.85
Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res (2012) 0.84
Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. J Neuroinflammation (2012) 0.83
Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration. J Neuroimmune Pharmacol (2013) 0.82
RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic rats. PLoS One (2013) 0.81
Involvement of the NLRP3 inflammasome in the modulation of an LPS-induced inflammatory response during morphine tolerance. Drug Alcohol Depend (2013) 0.80
Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment. J Neurovirol (2013) 0.80
A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systems. J Neuroimmunol (2011) 0.79
Altered gene expression in the spleen of adolescent rats following high ethanol concentration binge drinking. Int J Clin Exp Med (2011) 0.79
Expression and regulation of the mu opioid peptide receptor in TPA-differentiated HL-60 promyelocytic leukemia cells. Int Immunopharmacol (2006) 0.79
Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. Int J Clin Exp Med (2012) 0.78
Ethanol-induced FOS immunoreactivity in the brain of mu-opioid receptor knockout mice. Drug Alcohol Depend (2005) 0.78
Methamphetamine-mediated modulation of MOR expression in the SH-SY5Y neuroblastoma cell line. Synapse (2011) 0.77
Lipopolysaccharide-induced pro-inflammatory cytokines in the brain of rats in the morphine-tolerant state. J Neuroimmune Pharmacol (2008) 0.77
Interleukin-1 beta-induced up-regulation of opioid receptors in the untreated and morphine-desensitized U87 MG human astrocytoma cells. J Neuroinflammation (2012) 0.75
SNIP members in a recent international conference: World Summit of Antivirals. J Neuroimmune Pharmacol (2008) 0.75